Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Radujkovic A, Guglielmi C, Bergantini S, Iacobelli S, van Biezen A, Milojkovic D, Gratwohl A, Schattenberg AV, Verdonck LF, Niederwieser DW, de Witte T, Kröger N, Olavarria E; Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Radujkovic A, et al. Among authors: niederwieser dw. Biol Blood Marrow Transplant. 2015 Jul;21(7):1230-6. doi: 10.1016/j.bbmt.2015.03.012. Epub 2015 Mar 19. Biol Blood Marrow Transplant. 2015. PMID: 25797175 Free article.
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation.
Barkholt L, Hentschke P, Zetterquist H, Mattsson J, Uzunel M, Wersäll P, Martola J, Albin N, Aschan J, Wijkström H, Tillegård A, Oman S, Wernerson A, Niederwieser D, Thörne A, Ringdén O. Barkholt L, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1862-4. doi: 10.1016/s0041-1345(00)02726-3. Transplant Proc. 2001. PMID: 11267544 No abstract available.
HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia.
Clark RE, Hermans J, Madrigal A, Nachbaur D, Kropshofer G, Gratwohl A, Apperley J, Niederwieser D; Chronic Leukaemia Working Party of the European Group of Blood and Bone Marrow Transplantation. Clark RE, et al. Br J Haematol. 2001 Jul;114(1):36-41. doi: 10.1046/j.1365-2141.2001.02897.x. Br J Haematol. 2001. PMID: 11472342 Free article.
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation.
de Witte T, Pikkemaat F, Hermans J, van Biezen A, Mackinnan S, Cornelissen J, Gratwohl A, Delforge M, Iriondo A, Kuentz M, Harousseau J, Fauser A, Wandt H, Runde V, Niederwieser D, Apperley J; EBMT, CLWP-MDS subcommittee. de Witte T, et al. Leukemia. 2001 Dec;15(12):1878-84. doi: 10.1038/sj.leu.2402296. Leukemia. 2001. PMID: 11753608
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Urbano-Ispizua A, Schmitz N, de Witte T, Frassoni F, Rosti G, Schrezenmeier H, Gluckman E, Friedrich W, Cordonnier C, Socie G, Tyndall A, Niethammer D, Ljungman P, Gratwohl A, Apperley J, Niederwieser D, Bacigalupo A; European Group for Blood and Marrow Transplantation. Urbano-Ispizua A, et al. Bone Marrow Transplant. 2002 Apr;29(8):639-46. doi: 10.1038/sj.bmt.1703535. Bone Marrow Transplant. 2002. PMID: 12180107
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, Deliliers GL, Martino R, Russell N, Van Biezen A, Michallet M, Niederwieser D; Chronic Leukemia Working Party of the EBMT. Dreger P, et al. Leukemia. 2003 May;17(5):841-8. doi: 10.1038/sj.leu.2402905. Leukemia. 2003. PMID: 12750695 Review.
171 results